The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.
Open accessAbstract
The monokine, cachectin/tumor necrosis factor (TNF) differs from interleukin 1 (IL-1) in primary structure and in recognition by a distinct cellular receptor. It does, however, encode effector functions that are similar to those of IL-1 and characteristic of the host response to inflammation or tissue injury. Accordingly, we examined the possibility that recombinant-generated human TNF regulates hepatic acute-phase gene expression. In picomolar concentrations, TNF mediated reversible, dose- and time-dependent increases in biosynthesis of complement proteins factor B and C3, alpha 1 antichymotrypsin, and decreases in biosynthesis of albumin and transferrin in human hepatoma cell lines (Hep G2, Hep 3B). Biosynthesis of complement proteins C2 and C4, and alpha 1 proteinase inhibitor were not affected by TNF. TNF also increased factor B gene expression, but had no effect on C2 gene expression, in murine fibroblasts transfected with cosmid DNA bearing the human C2 and factor B genes. The effect of TNF on acute-phase protein expression (C3, factor B, albumin) was pre-translational as shown by changes in specific messenger RNA content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Old, L. J. (1985) · Science · doi:10.1126/science.2413547 · Cited by 1,895
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,579
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationDayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Roberts, B. E., & Paterson, B. M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2330 · Cited by 1,208
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Self-citationIdentity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationHuman tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., & Palladino, M. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2069 · Cited by 913
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 884
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B. A., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 763
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A., & Ringold, G. M. (1985) · Science · doi:10.1126/science.3839597 · Cited by 518
Collins, T., Lapierre, L. A., Fiers, W., Strominger, J. L., & Pober, J. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.446 · Cited by 482
Ramadori, G., Sipe, J. D., Dinarello, C. A., Mizel, S. B., & Colten, H. R. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.3.930 · Cited by 417
Self-citationAn update on human interleukin-1: From molecular biology to clinical relevance
Dinarello, C. A. (1985) · Journal of Clinical Immunology · doi:10.1007/bf00918247 · Cited by 374
Self-citationHuman interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki, K., Matsushima, K., Aggarwal, B. B., & Oppenheim, J. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3962 · Cited by 372
Sequential Changes of Plasma Proteins after Surgical Trauma
Aronsen, K.-F., Ekelund, G., Kindmark, C., & Laurell, C.-B. (1972) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517209102760 · Cited by 348
Kull, F. C., Jacobs, S., & Cuatrecasas, P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5756 · Cited by 281
Human leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Self-citationLipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.
Kawakami, M., Pekala, P. H., Lane, M. D., & Cerami, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.912 · Cited by 267
Woods, D. E., Markham, A. F., Ricker, A. T., Goldberger, G., & Colten, H. R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5661 · Cited by 233
Self-citationRecombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
Beutler, B. A., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3969 · Cited by 232
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis.
Lovett, D., Kozan, B., Hadam, M., Resch, K., & Gemsa, D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.1.340 · Cited by 160
Pekala, P. H., Kawakami, M., Angus, C., Lane, M. D., & Cerami, A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2743 · Cited by 141
Regulation of Class III Major Histocompatibility Complex Gene Products by Interleukin-1
Perlmutter, D. H., Goldberger, G., Dinarello, C. A., et al. (1986) · Science · doi:10.1126/science.3010455 · Cited by 125
Self-citationStrunk, R. C., Whitehead, A. S., & Cole, F. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112099 · Cited by 95
Woloski, B. M. R. N. J., & Fuller, G. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1443 · Cited by 82
Kurnit, D. M., Philipp, B. W., & Bruns, G. A. P. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000131818 · Cited by 32
Expression of complement proteins C2 and factor B in transfected L cells.
Perlmutter, D. H., Colten, H. R., Grossberger, D., Strominger, J. L., Seidman, J. G., & Chaplin, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112123 · Cited by 24
Self-citation
Cited by
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Dinarello, C. A. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277884 · Cited by 1,532
Self-citation
Metadata
- Authors
- Perlmutter, D. H., Dinarello, C. A., Punsal, P. I., & Colten, H. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1986-11-01
- Volume
- 78
- Issue
- 5
- Pages
- 1349-1354
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965952579
- Cited by
- 574
- References
- 35
- FWCI
- 26.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.